Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs-Reference-Cited by-同舟云学术

Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs

Published:2019-05-10 Issue:5 Volume:14 Page:e0215607
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Clemens Daniel L.^ORCID,Lee Bai-Yu,Silva Aleidy^ORCID,Dillon Barbara Jane,Masleša-Galić Saša,Nava Susana,Ding Xianting^ORCID,Ho Chih-Ming^ORCID,Horwitz Marcus A.

Funder

Shanghai Jiao Tong University, a grantee of the Bill and Melinda Gates Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. World Health Organization (2018) Global tuberculosis report 2018. http://wwwwhoint/tb/publications/global_report/en/.

2. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update;D Falzon;Eur Respir J,2017

3. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis;EW Orenstein;Lancet Infect Dis,2009

4. Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model;A Silva;Proc Natl Acad Sci U S A,2016

5. Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time;B-Y Lee;Nat Commun,2017

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfer learning predicts species-specific drug interactions in emerging pathogens;2024-06-06

2. Radiation therapy with phenotypic medicine: towards N-of-1 personalization;British Journal of Cancer;2024-03-21

3. Discovery of Broad‐Spectrum Repurposed Drug Combinations Against Carbapenem‐Resistant Enterobacteriaceae (CRE) Through Artificial Intelligence (AI)‐Driven Platform;Advanced Therapeutics;2024-01-18

4. Multiomics technologies applied to tuberculosis drug discovery;Biological Insights of Multi-Omics Technologies in Human Diseases;2024

5. Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial;Emerging Microbes & Infections;2023-03-17